Weiz­mann, Pfizer sign co­op­er­a­tion deal

The Jerusalem Post - - NEWS -

The Weiz­mann In­sti­tute of Science an­nounced a multi-year deal Mon­day with global phar­ma­ceu­ti­cal gi­ant Pfizer.

The deal, which was signed through Weiz­mann’s commercial arm, will see Pfizer in­stalling a medic­i­nal chemist on an an­nual, ro­tat­ing ba­sis at the In­sti­tute’s Na­tional Drug Dis­cov­ery In­sti­tute (DDI). The DDI is part of Weiz­mann’s Nancy and Stephen Grand Is­rael Na­tional Cen­ter for Per­son­al­ized Medicine (G-INCPM). “This is an ex­cit­ing part­ner­ship for Pfizer,” said Mikael Dol­sten, Pres­i­dent of Pfizer Global Re­search.

“We have in­ter­acted with the Weiz­mann In­sti­tute for many years and have con­fi­dence in their sci­en­tific vi­sion and ex­per­tise. We an­tic­i­pate that this ar­range­ment could po­ten­tially re­sult in mean­ing­ful dis­cov­er­ies in the com­ing years.” • Niv Elis

Newspapers in English

Newspapers from Israel

© PressReader. All rights reserved.